Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Drug pricing and PBMs pressed at hearing; nominee backs transparency and negotiations but gives few commitments
Summary
Pharmacy benefit managers and drug pricing drew sustained attention at the Senate Finance Committee hearing; the nominee said he supports PBM accountability and lower U.S. drug prices but stopped short of legal commitments.
Pharmacy benefit managers (PBMs), prescription drug pricing and Medicare negotiation authority were central policy topics at the Senate Finance Committee hearing for Robert F. Kennedy Jr.
Sen. Chuck Grassley and others asked Kennedy to back PBM accountability measures and drug–price transparency, including proposals to require price disclosures in direct‑to‑consumer advertising. Kennedy said he supports holding PBMs accountable and described drug price negotiation as a priority, saying "we should end that disparity" of higher U.S. drug prices compared with other countries.
Why it matters: Drug prices are a major contributor to health costs for…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
